Keep in a cool place: Exposure of medicines to high temperatures in general practice during a British heatwave

Journal of the Royal Society of Medicine

Volumn 97, Issue 7, 2004, Pages 328-329

  Crichton, Brian ^a  

^a Hobs Moat Medical Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CEFOTAXIME; CHLORPHENIRAMINE; CHLORPROMAZINE; DIAMORPHINE; DIAZEPAM; DICLOFENAC; FUROSEMIDE; GLUCOSE; HYDROCORTISONE; NALOXONE; PENICILLIN G; PETHIDINE; PROCHLORPERAZINE;

AIR CONDITIONING; ARTICLE; CAR; DRUG STORAGE; ENVIRONMENTAL TEMPERATURE; HIGH TEMPERATURE; THERMAL EXPOSURE;

EID: 3142676010     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.97.7.328     Document Type: Article

References (9)

1. US Pharmacopeia, Vol 26. Rockville, MD: USP, 2000
2. Rudland SV, Jacobs AG. Visiting bags: a labile thermal environment. BMJ 1994;308:954-6
3. Rudland SV, Annus T. Adrenaline activity is not significantly altered by high ambient temperatures. Emerg Med 1997;9:109-11
4. Rudland SV, Annus T, Dickinson J, Langdon S. Adrenaline degradation in general practice. Br J Gen Tract 1997;47:827-8
5. Molokhia AM. Effect of storage on the bioavailability of cephalexin from its capsules. Res Commun Chem Pathol Pharmacol 1984;45:219-24
6. Ballereau F, Prazuck T, Schrive I, et al. Stability of essential drugs in the field: results of a study conducted over a two-year period in Burkina Faso. Am J Trop Med Hyg 1997;57:31-6
7. Risha PG, Vervaet C, Vergote G, Bortel LV, Remon JP. Drug formulations intended for the global market should be tested for stability under tropical climatic conditions. Eur J Clin Pharmacol 2003;59:135-41
8. [http://emc.medicines.org.uk] accessed 21 April 2004
9. US Pharmacopeia, Vol 28. Rockville, MD: USP, 2002:2232-3